• EnClear Spins out of QurAlis americanpharmaceuticalreview
    December 29, 2018
    EnClear Therapies has spun-out from QurAlis Corporation, a biotech company focused on developing precision therapeutics for ALS and other neurological diseases. EnClear’s mission is to halt the progression of ....
PharmaSources Customer Service